ActoFactor™ Recombinant Human Vascular Endothelial Cell Growth Factor B
- Specification
 - Q & A
 - Customer Review
 
Cat.No.
CSC-CTK0391
Description
VEGF-B, a member of the VEGF family, is a potent growth and angiogenic cytokine. It promotes DNA synthesis in endothelial cells, helps regulate angiogenesis and vascular permeability, and inhibits apoptosis in certain smooth muscle cells and neurons. VEGF-B is expressed in all tissues except the liver. It forms cell surfaced-associated disulfide linked homodimers and can form heterodimers with VEGF-A. There are two known isoforms, formed by alternative splicing, which have been designated VEGF-B167 and VEGF-B186. Both forms have identical amino-terminal sequences encoding a "cysteine knot" like structural motif, but differ in their carboxyl-terminal domains. Both VEGF-B isoforms signal only through the VEGFR1 receptor. Recombinant human VEGF-B is a 38.0 kDa disulfide-linked homodimeric protein consisting of two 167 amino acid polypeptide chains.
Species
                                Human
                            Product Overview
                                Human FLT1 expressed in E.coli
                            Molecular Mass
                                38.0 kDa
                            Size
                                CAT# CSC-CTK0391-20 (20 μg); CAT# CSC-CTK0391-100 (100 μg)
                            Expression System
                                E.coli
                            Purity
                                Greater than 98% as determined by SDS-PAGE and HPLC analysis.
                            Activity
                                Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVECs) in the presence of human VEGF165. The expected ED50 for this effect is 1.0 - 2.0 μg/ml.
                            Endotoxin Level
                                Less than 1 EU/μg.
                            Formulation
                                Lyophilized from 10 mM Acetic Acid.
                            Reconstitution
                                Please centrifuge product before opening vial. The lyophilized protein should be reconstituted with distilled, sterile water to a concentration of 0.1-1.0 mg/ml. For further dilution, carrier protein (0.1% BSA or HSA) should be added to avoid loss of bioactivity.
                            Storage & Stability
                                The lyophilized protein, though stable at room temperature for up to 3 weeks, is best stored desiccated at -20°C. Reconstituted protein should be used immediately or stored long-term in undiluted working aliquots at -20°C. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze-thaw cycles.
                            Citation Guidance
                        
                            If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no.
                            
                                If your paper has been published, please click here
                                to submit the PubMed ID of your paper to get a coupon.
                            
                        
                    Ask a Question
Write your own review